ES2193192T3 - Receptores de interleuquina-15. - Google Patents

Receptores de interleuquina-15.

Info

Publication number
ES2193192T3
ES2193192T3 ES95918389T ES95918389T ES2193192T3 ES 2193192 T3 ES2193192 T3 ES 2193192T3 ES 95918389 T ES95918389 T ES 95918389T ES 95918389 T ES95918389 T ES 95918389T ES 2193192 T3 ES2193192 T3 ES 2193192T3
Authority
ES
Spain
Prior art keywords
interleuquine
receivers
il15r
adns
recombinating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95918389T
Other languages
English (en)
Inventor
Dirk M Anderson
Judith G Giri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ES2193192T3 publication Critical patent/ES2193192T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE DESCRIBEN PROTEINAS DEL RECEPTOR DE LA INTERLEUQUINA-15 (IL15R), ADNS Y VECTORES DE EXPRESION QUE CODIFICAN LA IL-15R, Y PROCESOS PARA LA PRODUCCION DE IL-15R COMO PRODUCTOS DE CULTIVOS DE CELULAS RECOMBINANTES.
ES95918389T 1994-05-06 1995-05-04 Receptores de interleuquina-15. Expired - Lifetime ES2193192T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23691994A 1994-05-06 1994-05-06
US08/300,903 US5591630A (en) 1994-05-06 1994-09-06 Monoclonal antibodies that bind interleukin-15 receptors

Publications (1)

Publication Number Publication Date
ES2193192T3 true ES2193192T3 (es) 2003-11-01

Family

ID=26930223

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95918389T Expired - Lifetime ES2193192T3 (es) 1994-05-06 1995-05-04 Receptores de interleuquina-15.

Country Status (11)

Country Link
US (1) US5591630A (es)
EP (1) EP0759942B1 (es)
AT (1) ATE233788T1 (es)
AU (1) AU695798B2 (es)
CA (1) CA2188279C (es)
DE (1) DE69529822T2 (es)
DK (1) DK0759942T3 (es)
ES (1) ES2193192T3 (es)
NZ (1) NZ285292A (es)
PT (1) PT759942E (es)
WO (1) WO1995030695A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548065B1 (en) * 1994-05-06 2003-04-15 Immunex Corporation Interleukin-15 receptors
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
WO1998016254A1 (en) 1996-10-17 1998-04-23 Immunomedics, Inc. Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
DE69810091T2 (de) * 1997-02-21 2003-10-09 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw., Zwijnaarde Verwendung von interleukin-15
JP2002519439A (ja) * 1998-07-07 2002-07-02 久光製薬株式会社 Ｉｌ−１５に標的されたアンチセンスオリゴヌクレオチド
US6794187B2 (en) * 2000-03-03 2004-09-21 University Of Utah Research Foundation Mass1 gene, a target for anticonvulsant drug development
US7329405B2 (en) * 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
US7247304B2 (en) * 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
IL160358A0 (en) * 2001-08-23 2004-07-25 Genmab As Human antibodies specific for interleukin 15 (il-15)
PL1899364T5 (pl) 2005-05-17 2024-12-09 University Of Connecticut Kompozycje i sposoby immunomodulacji w organizmie
EP1777294A1 (en) 2005-10-20 2007-04-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
EP1984505B1 (en) 2006-01-13 2019-12-25 The Government of the U.S.A., as repr. by the Secretary, Dept. of Health & Human Services, the Nat. Inst. of Health Codon optimized il-15 and il-15r-alpha genes for expression in mammalian cells
CA2691785C (en) 2007-06-27 2017-01-10 Marine Polymer Technologies Inc. Complexes of il-15 and il-15ralpha and uses thereof
EP3135294B1 (en) 2009-08-14 2020-06-03 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Use of il-15-il-15 receptor heterodimers to treat lymphopenia
WO2011031986A1 (en) 2009-09-10 2011-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer, National Institutes Of Health Assays for soluble il-15 receptor alpha
WO2014066527A2 (en) 2012-10-24 2014-05-01 Admune Therapeutics Llc Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes
KR102539359B1 (ko) 2013-04-19 2023-06-02 싸이튠 파마 감소된 혈관 누출 증후군에 대한 사이토카인 유도체 치료
WO2016018920A1 (en) 2014-07-29 2016-02-04 Admune Therapeutics Llc Il-15 and il-15ralpha heterodimer dose escalation regimens for treating conditions
US11472856B2 (en) 2016-06-13 2022-10-18 Torque Therapeutics, Inc. Methods and compositions for promoting immune cell function
KR20210032924A (ko) 2017-09-05 2021-03-25 토크 테라퓨틱스, 인코포레이티드 치료용 단백질 조성물 및 그의 제조 및 사용 방법
CN112795543B (zh) * 2021-02-04 2022-09-27 华中农业大学 杂交瘤细胞株及其分泌的抗草鱼IL-15Rα单克隆抗体和应用
US20260048099A1 (en) 2022-08-16 2026-02-19 The United States Of America, As Represented By The Secretary, Deparment Of Health And Human Service Synergistic interactions for improved cancer treatment

Also Published As

Publication number Publication date
ATE233788T1 (de) 2003-03-15
DK0759942T3 (da) 2003-06-10
AU695798B2 (en) 1998-08-20
US5591630A (en) 1997-01-07
CA2188279C (en) 2010-01-26
DE69529822D1 (de) 2003-04-10
PT759942E (pt) 2003-07-31
EP0759942B1 (en) 2003-03-05
CA2188279A1 (en) 1995-11-16
EP0759942A4 (en) 1999-05-12
EP0759942A1 (en) 1997-03-05
WO1995030695A1 (en) 1995-11-16
AU2434495A (en) 1995-11-29
DE69529822T2 (de) 2003-12-11
NZ285292A (en) 1998-08-26

Similar Documents

Publication Publication Date Title
AR241314A1 (es) Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional.
ES2145451T3 (es) Secuencia de dna y proteina de cancer de mamas codificada especifica para mamas.
DE69739366D1 (de) Aktive und inactive CC-Chemokinrezeptoren und Nukleinsäuremoleküle, die für diesen Rezeptor kodieren
ATE369346T1 (de) Halogenpyrimidinylaryl(thio)ether als pestizide
DE69426033D1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
NO900770L (no) Produksjon av glykoseoksidase i rekombinante systemer.
FI963070A0 (fi) Klooripyrimidiinivälituotteita
DE3586697D1 (en) Aktive thymopentin-analoga.
ES2125864T3 (es) Vectores bacterianos.
DE69413039D1 (de) Prostaglandin rezeptor fp und kodierende dns
ATE236932T1 (de) Dna kodierend für prostaglandin rezeptor ip
ES2191011T3 (es) Acido nucleico, vector de expresion y composiciones para la identificacion y sintesis de sialiltransferasas recombinantes.
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
DE59610251D1 (de) Konjugat, umfassend einen wirkstoff, ein polypeptid und einen polyether
TR199802512T2 (xx) Plastik par�alar�n asamblaj�n�n y�ksek h�zda asamblaj� i�in proses.
AR246310A1 (es) Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante.
ES2048142T3 (es) Procedimiento de obtencion de polidesoxirribonucleotidos sustancialmente puros y no informacionales que tienen actividades biologicas, y producto respectivo.
ES2061787T3 (es) Combinacion de inhibidores de la enzima de conversion de la angiotensina con moduladores del canal del potasio, asi como su empleo en medicamentos.
DE69120390D1 (de) Kollagen-bindendes protein sowie dessen herstellung
MX9307007A (es) Vectores de expresion para tripsina y tripsinogeno de bovino y celulashuesped transformadoras con los mismos.
ES2175246T3 (es) Reticulante pobre en reversion.
HUT41002A (en) Process for preparing anticonvulsives
ES2183515T3 (es) Peptidomimeticos de azol utilizados como antagonistas del receptor de la trombina.
ATE207757T1 (de) Für die immun- und cns-therapie nutzbare, neuartige tripeptide
ATE234841T1 (de) Nodulisporinsäurederivate